Catalyst Wire Dossier Catalyst Wire Dossier

Fluticasone Propionate 250 mcg Inhalation Powder

fluticasone propionate · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fluticasone Propionate 250 mcg Inhalation Powder, covering 2017-06-12 to 2017-06-12. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma [Phase 3]

See pricing